This page collects WhisperX intelligence signals tagged #ADC. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
A four-month FDA delay has forced a cash-strapped biotech company to shutter, highlighting the existential threat regulatory holdups pose to small drugmakers while larger players like Neurocrine Biosciences execute multi-billion dollar acquisitions. This stark contrast underscores the high-stakes, winner-take-all press...
Gilead Sciences is making a massive strategic move into a fiercely competitive field, agreeing to acquire the private German biotech firm Tubulis in a deal valued at up to $5 billion. This acquisition is a direct and costly bid to rapidly build a dominant position in a cutting-edge and highly sought-after area of oncol...